These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 15842575

  • 21. Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.
    Tolia V, Gilger MA, Barker PN, Illueca M.
    J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):593-8. PubMed ID: 20706150
    [Abstract] [Full Text] [Related]

  • 22. Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.
    Johnson DA, Benjamin SB, Vakil NB, Goldstein JL, Lamet M, Whipple J, Damico D, Hamelin B.
    Am J Gastroenterol; 2001 Jan; 96(1):27-34. PubMed ID: 11197282
    [Abstract] [Full Text] [Related]

  • 23. Esomeprazole relieves upper gastrointestinal symptoms in high-risk and average-risk NSAID users in daily clinical practice: results from an open-label study.
    Tielemans MM, van Oijen MG, Mulder CJ, Vos KJ, Lems WF.
    Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):281-7. PubMed ID: 22246328
    [Abstract] [Full Text] [Related]

  • 24. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F, De Luca L, Graham DY.
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
    [Abstract] [Full Text] [Related]

  • 25. New NSAIDs and gastroduodenal damage.
    Folco GC.
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():28-9. PubMed ID: 9032579
    [Abstract] [Full Text] [Related]

  • 26. Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?
    Talley NJ, Vakil N, Lauritsen K, van Zanten SV, Flook N, Bolling-Sternevald E, Persson T, Björck E, Lind T, STARS I Study Group.
    Aliment Pharmacol Ther; 2007 Sep 01; 26(5):673-82. PubMed ID: 17697201
    [Abstract] [Full Text] [Related]

  • 27. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study.
    Nørgård B, Pedersen L, Johnsen SP, Tarone RE, McLaughlin JK, Friis S, Sørensen HT.
    Aliment Pharmacol Ther; 2004 Apr 01; 19(7):817-25. PubMed ID: 15043523
    [Abstract] [Full Text] [Related]

  • 28. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
    Bensen WG, Zhao SZ, Burke TA, Zabinski RA, Makuch RW, Maurath CJ, Agrawal NM, Geis GS.
    J Rheumatol; 2000 Aug 01; 27(8):1876-83. PubMed ID: 10955327
    [Abstract] [Full Text] [Related]

  • 29. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial.
    Chan FK, Wong VW, Suen BY, Wu JC, Ching JY, Hung LC, Hui AJ, Leung VK, Lee VW, Lai LH, Wong GL, Chow DK, To KF, Leung WK, Chiu PW, Lee YT, Lau JY, Chan HL, Ng EK, Sung JJ.
    Lancet; 2007 May 12; 369(9573):1621-6. PubMed ID: 17499604
    [Abstract] [Full Text] [Related]

  • 30. COX-2-selective inhibitors (COXIBs): gastrointestinal safety.
    Pronai L, Hritz I, Molnar B, Herszenyi L, Tulassay Z.
    Int J Immunopathol Pharmacol; 2003 May 12; 16(2 Suppl):23-30. PubMed ID: 14552701
    [Abstract] [Full Text] [Related]

  • 31. Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.
    Devault KR, Johanson JF, Johnson DA, Liu S, Sostek MB.
    Clin Gastroenterol Hepatol; 2006 Jul 12; 4(7):852-9. PubMed ID: 16682260
    [Abstract] [Full Text] [Related]

  • 32. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN, Callaghan R, Allen ME, Rowe IF.
    Rheumatology (Oxford); 2005 Jul 12; 44(7):921-4. PubMed ID: 15827035
    [Abstract] [Full Text] [Related]

  • 33. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study.
    Kiljander TO, Junghard O, Beckman O, Lind T.
    Am J Respir Crit Care Med; 2010 May 15; 181(10):1042-8. PubMed ID: 20110554
    [Abstract] [Full Text] [Related]

  • 34. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
    Chan FK, Hung LC, Suen BY, Wu JC, Lee KC, Leung VK, Hui AJ, To KF, Leung WK, Wong VW, Chung SC, Sung JJ.
    N Engl J Med; 2002 Dec 26; 347(26):2104-10. PubMed ID: 12501222
    [Abstract] [Full Text] [Related]

  • 35. A randomized, double-blind, crossover comparative endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen.
    Bjarnason I, Macpherson A, Rotman H, Schupp J, Hayllar J.
    Scand J Gastroenterol; 1997 Feb 26; 32(2):126-30. PubMed ID: 9051872
    [Abstract] [Full Text] [Related]

  • 36. Inadequate prevention of NSAID-induced gastrointestinal events.
    Herings RM, Goettsch WG.
    Ann Pharmacother; 2004 May 26; 38(5):760-3. PubMed ID: 15031416
    [Abstract] [Full Text] [Related]

  • 37. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.
    Rheumatology (Oxford); 2003 Nov 26; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [Abstract] [Full Text] [Related]

  • 38. [Are COX-2 inhibitors truly able to prevent NSAIDs-associated ulcer?].
    Nishida T, Tsujii M, Tsuji S.
    Nihon Rinsho; 2004 Mar 26; 62(3):561-5. PubMed ID: 15038104
    [Abstract] [Full Text] [Related]

  • 39. Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - a randomized study comparing ranitidine with esomeprazole.
    Goldstein JL, Johanson JF, Hawkey CJ, Suchower LJ, Brown KA.
    Aliment Pharmacol Ther; 2007 Oct 15; 26(8):1101-11. PubMed ID: 17894652
    [Abstract] [Full Text] [Related]

  • 40. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC.
    Semin Arthritis Rheum; 2002 Dec 15; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.